Main Page Article Search E-Lerts™ Newsletter: Current E-Lerts™ Newsletter Archives E-Lerts™ Newsletter Recipes Archives Defeat Diabetes® E-Lerts™ Newsletter Subscribe Defeat Diabetes ® News by Daniel H. Rasolt Books You Can Use™ Subscribe to Defeat Diabetes Foundation Mailings
About Diabetes Body Care Children Complications Defeat Diabetes Foundation Drugs Elderly E-Lerts™ Governments & Organizations Health & Fitness Insulin MADDCAP™ Mr. Diabetes® Nutrition Obesity Other Diseases Pregnancy Research Risks Self-Management Supplements Type 1 Warning Signs

 

 

 

     

Search our News Articles Archives for diabetes and health news. Search by word or phrase.  The latest article will appear first.

Search For:  

Search in all categories / subcategories
Search in current category / subcategory

Pfizer, Bayer Partner on Fat Modifier Obesity Drugs Posted: Friday, June 23, 2006

Pfizer is buying exclusive worldwide rights to an experimental class of Bayer obesity drugs.

Short Term Economic Impact of Weight Change Among Patients with Type 2 Diabetes Posted: Thursday, June 15, 2006

A 1 percent weight loss was associated with a 5.6 percent decrease in health care costs, or approximately $408.

Investigational Januvia (MSD) Put Through Its Paces for Diabetes Posted: Thursday, June 15, 2006

Researchers reported that, Januvia (sitagliptin), an investigational oral agent for type 2 diabetes, appears to be effective when given as a monotherapy or as an adjunct to Glucophage (metformin) or Actos (pioglitazone). FDA approval expected soon.

New Oral Insulin Shows Safety, Feasibility in Trials Posted: Thursday, June 15, 2006

In the first human trials of oral insulin, the drug acted within 15 minutes and showed 60%-70% of the biopotency of injected insulin, without causing any adverse effects, researchers reported here at the 66th Scientific Sessions of the American Diabetes Association.

Study Shows New Non-Invasive Device Screens Diabetes Better Than Fasting Plasma Glucose Test Posted: Thursday, June 15, 2006

Diabetes biomarkers found in skin shown to Correlate well with diabetes risk.

Many Doctors Aren't Treating Diabetes Aggressively Enough Posted: Thursday, June 15, 2006

FOUR studies find that this is true for patients with high blood pressure, and elevated blood sugar.

Once-Weekly BYETTA (Exenatide) LAR Improves Glucose Control in Patients with Type 2 Diabetes Posted: Thursday, June 15, 2006

Reduces A1c by 2 points and average weight lose of 8 pounds in 15 weeks.

High Postmenopausal Sex Hormones Signal Type 2 Diabetes Risk Posted: Thursday, June 15, 2006

Postmenopausal women with high levels of estradiol and testosterone are at a greatly increased risk of developing type 2 diabetes, according to data on nearly 28,000 women.

Women with Preeclampsia Have Double the Type 2 Diabetes Risk Posted: Thursday, June 15, 2006

Researchers reported that preeclampsia is an independent risk marker for type 2 diabetes, even when gestational diabetes is taken into account.

Ten Thousand Patients Using Levemir Insulin Show Improvements in BG Without Weight Gain Posted: Thursday, June 15, 2006

Levemir reduced mean A1C levels by 0.54 percent for type 1 and 0.89 percent for type 2 diabetes patients.

 

 

 

 

 

 Costa Rica Travel Corp. will donate a portion of the proceeds to and is a sponsor of Defeat Diabetes Foundation.